Data-Driven Care Planning for Multimorbidity (VET-PATHS)

November 13, 2026 updated by: VA Office of Research and Development

Optimizing Primary Care Delivery: Data-Driven Care Planning to Improve Veteran Health Outcomes

The objective of this study is to compare the effectiveness of VET-PATHS (VETeran PAnel Management Tool for High-Risk Subgroups), a novel data-driven panel management tool, to a standard high-risk patient list tool for helping VA primary care teams manage Veterans at highest risk for hospitalization and poor health outcomes.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

VET-PATHS is designed to use data and technology to facilitate proactive panel management for high-risk Veterans by:

  1. batching high-risk patients into subgroups with similar health profiles and care needs using advanced clustering models,
  2. identifying key gaps in evidence-based care for each patient, and
  3. jumpstarting individualized, proactive care plans through automated prompts delivered directly to frontline care teams.

Patient Aligned Care Teams (PACTs) will be randomized to use VET-PATHS or a standard high-risk patient list during team meetings facilitated by study staff over 6 months.

Study Type

Interventional

Enrollment (Estimated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15240
        • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
        • Contact:
        • Principal Investigator:
          • Ann-Marie Rosland, MD MS
        • Sub-Investigator:
          • Karin S Daniels, PhD
        • Principal Investigator:
          • Linnaea Schuttner, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Research participants are VA clinical staff on general primary care teams (includes women's health primary care teams) with:

  • Team-assigned PCP >/= 0.5 Full-Time-Equivalent (FTE)
  • Team panel patients (active, total) >/= 600
  • Core staff positions filled at time of enrollment (Clinical associate, RN care manager)

Exclusion Criteria:

  • Team focuses solely on a specialized type of primary care patient. For example, teams that focus on patients with housing instability, HIV, or spinal cord disorders
  • Home-Based Primary Care teams are also excluded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: VET-PATHS

Teams use VET-PATHS tool for panel management

Population Management Tool for patients empaneled to primary care teams and at high-risk for hospitalization, divided into multimorbidity profiles (subgroups), with suggested Care Plan elements based on patient medical record data.

Other Names:
  • Veteran Panel Management Tool for High-Risk Subgroups
Active Comparator: Standard Tool

Teams use a Standard tool for panel management

Standard population management tool that identifies patients empaneled to primary care teams at high risk for hospitalization.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
High-Risk Patient Care Plan delivery
Time Frame: 6 months

Percent of empaneled patients in the top 10th percentile of hospitalization risk with a new High-Risk Patient Care Plan documented in the EHR within 6 months following intervention.

6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Ann-Marie Rosland, MD MS, VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
  • Principal Investigator: Linnaea Schuttner, MD, VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2027

Primary Completion (Estimated)

May 1, 2029

Study Completion (Estimated)

September 1, 2030

Study Registration Dates

First Submitted

November 12, 2026

First Submitted That Met QC Criteria

November 13, 2026

First Posted (Actual)

November 19, 2026

Study Record Updates

Last Update Posted (Actual)

November 19, 2026

Last Update Submitted That Met QC Criteria

November 13, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • HSR1-016-25M

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.